{"organizations": [], "uuid": "4b5714e0ff2ee8237559e9a97c585246b215c509", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 1, "shares": 1, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-therapix-biosciences-announces-exp/brief-therapix-biosciences-announces-expansion-into-precision-medicine-through-new-fully-owned-subsidiary-idUSASB0C0DG", "country": "US", "domain_rank": 408, "title": "BRIEF-Therapix Biosciences Announces Expansion Into Precision Medicine Through New Fully-Owned Subsidiary", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-09T15:44:00.000+02:00", "replies_count": 0, "uuid": "4b5714e0ff2ee8237559e9a97c585246b215c509"}, "author": "", "url": "https://www.reuters.com/article/brief-therapix-biosciences-announces-exp/brief-therapix-biosciences-announces-expansion-into-precision-medicine-through-new-fully-owned-subsidiary-idUSASB0C0DG", "ord_in_thread": 0, "title": "BRIEF-Therapix Biosciences Announces Expansion Into Precision Medicine Through New Fully-Owned Subsidiary", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-therapix biosciences", "sentiment": "negative"}, {"name": "therapix biosciences ltd", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "precision medicine through new fully-owned subsidiary reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 9, 2018 / 1:47 PM / Updated 11 minutes ago BRIEF-Therapix Biosciences Announces Expansion Into Precision Medicine Through New Fully-Owned Subsidiary Reuters Staff 1 Min Read \nJan 9 (Reuters) - Therapix Biosciences Ltd: \n* THERAPIX BIOSCIENCES ANNOUNCES EXPANSION INTO PRECISION MEDICINE THROUGH NEW FULLY-OWNED SUBSIDIARY AND PROVIDES CORPORATE UPDATE TODAY AT THE BIOTECH SHOWCASE™ 2018 \n* THERAPIX BIOSCIENCES LTD - ‍EXPANDING INTO PRECISION MEDICINE THROUGH A NEW FULLY-OWNED SUBSIDIARY IN ORDER TO DEVELOP “NOVEL SOLUTIONS FOR PAIN”​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-09T15:44:00.000+02:00", "crawled": "2018-01-09T16:02:21.002+02:00", "highlightTitle": ""}